Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-07-02

Clinical Trial Results: Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results of lenalidomide in advanced or unresectable kidney cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lenalidomide (lenalidomide)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED | Results posted: 2026-07-02